Tox is very severe and the cost of drug plus managing the side effects is massively expensive. So the risk / benefit and health economics are worse in early sta

Tox is very severe and the cost of drug plus managing the side effects is massively expensive. So the risk / benefit and health economics are worse in early stage cancer. They'll study it in earlier stage at some point probably